Clinical Trials Sponsored by Duke University

Total 220995 results

Daniel George, MD
AstraZeneca

Withdrawn

TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer (TRIO Bladder)

Bladder Cancer

United States
Duke University
American College of Rheumatology

Completed

Rheumatoid Arthritis Coping Enhancement (EMBRACE)

Pain | Obesity | Rheumatoid Arthritis

United States
Jenny Tong, MD, MPH

Withdrawn

Effect of Ghrelin on Decision-Making

Obesity | Healthy Volunteers

United States
Duke University
Janssen Research & Development, LLC

Completed

CTC Immune Checkpoint

Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit

Smoking | Pregnancy

United States
Duke University
American Cancer Society, Inc.

Completed

Pain Coping Skills for Colorectal Cancer Survivors

Colorectal Cancer

United States
Richard Bedlack, M.D., Ph.D.

Completed

ALS Reversals - Lunasin Regimen

ALS (Amyotrophic Lateral Sclerosis)

United States
Duke University
National Comprehensive Cancer Network

Withdrawn

Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC (IMGN853)

Breast Cancer Triple Negative

United States
Joanne Kurtzberg, MD
Aldagen

Completed

Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells

Anemia, Aplastic | MDS | Inborn Errors of Metabolism | Congenital Marrow Failure | Congenital Immunodeficiency Syndrome

United States
Duke University
Merck Sharp & Dohme LLC

Completed

Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy

Postoperative Nausea and Vomiting

United States
Duke University
National Cancer Institute (NCI)

Completed

DAMES: Daughters And MothErS Against Breast Cancer

Breast Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel

Breast Cancer

United States
Dana Portenier, MD
Allergan

Terminated

Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding

Morbid Obesity

United States
Daniel George, MD
Novartis

Completed

Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors (PTK/RAD)

Kidney Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Duke University
Merck Sharp & Dohme LLC

Completed

Clinical Outcomes and Cost of Gram Negative Bacteremia

Bacteremia | Gram-negative Bacteremia

United States
Duke University
Merck Sharp & Dohme LLC

Completed

A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

Pancreatitis

United States
Duke University
Durham VA Medical Center

Completed

Contingency Management for Smoking Cessation in Homeless Smokers

Smoking | Homeless Persons

United States
Duke University
Philip Morris USA, Inc.

Terminated

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants (LiveForLife2)

Nicotine Dependence | Cigarette Smoking

United States
Duke University
National Cancer Institute (NCI)

Completed

Intervention Study of Communication in Oncologist-Patient Encounters (COPE)

Advanced Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Duke University
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Brain and Central Nervous System Tumors | Metastatic Cancer | Neuroblastoma

United States
Duke University
National Cancer Institute (NCI)

Completed

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors

United States
Duke University
Eli Lilly and Company

Terminated

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer (TOP0703)

Carcinoma, Non-Small-Cell Lung

United States
Duke University
National Cancer Institute (NCI)

Terminated

Testing Pharmacological Therapies for Pregnant Smokers

Smoking | Pregnancy

United States
Duke University
National Cancer Institute (NCI)

Completed

Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Tailored Intervention Protocol for Oral Chemotherapy Adherence

Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Advanced Cancer

Breast Cancer | Gastric Cancer | Ovarian Cancer

United States
Duke University
Merck Sharp & Dohme LLC

Completed

Once-Daily Asenapine for Schizophrenia

Schizophrenia

United States
Duke University
Genentech, Inc.; Schering-Plough

Completed

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas

Glioblastoma | Brain Tumor | Gliosarcoma

United States
Duke University
Merck Sharp & Dohme LLC

Completed

Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias

Alzheimer's Disease | Dementias

United States
Mitchell Horwitz, MD
Pfizer

Terminated

Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant

Allogeneic Stem Cell Transplantation

United States
Duke University
National Comprehensive Cancer Network

Terminated

Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

Prostate Cancer

United States
Duke University
National Cancer Institute (NCI)

Terminated

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Pancreatic Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
Massachusetts General Hospital; GlaxoSmithKline

Completed

Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy

Stress Disorders, Post-Traumatic

United States
Duke University
Genentech, Inc.; Schering-Plough

Completed

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Glioblastoma Multiforme

United States
Duke University
National Cancer Institute (NCI)

Withdrawn

Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Duke University
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

Melanoma (Skin)

United States
Duke University
National Cancer Institute (NCI)

Completed

Flt3L in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Duke University
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

Brain and Central Nervous System Tumors

United States
Duke University
Robert C. Atkins Foundation

Completed

Diet, Imaging and Energy Balance Trial (DIET) (DIET)

Obesity

United States
Duke University
Genentech, Inc.; Eisai Inc.

Terminated

A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme | Malignant Glioma | Gliosarcoma

United States
Duke University
Wallace H. Coulter Foundation

Completed

The Effects of Antihistamines on Pre-Pulse Inhibition (PPI)

Healthy

United States
David Rizzieri
Eleos, Inc.

Terminated

EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lymphoma, Small Lymphocytic | Leukemia, Lymphocytic, Chronic

United States
Michael Morse, MD
Immunotope

Completed

A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer

Epithelial Ovarian, Tubal or Peritoneal Cancer

United States
Duke University
Substance Abuse and Mental Health Services Administration (SAMHSA); The Duke...

Completed

Emergency Department Acupuncture for Acute Musculoskeletal Pain Management

Musculoskeletal Pain

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute

Terminated

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)

Idiopathic Pulmonary Fibrosis

United States
Duke University
Makerere University; Uganda Cancer Institute

Not yet recruiting

KeyScope Study in Uganda

Abdominal Neoplasm

Uganda
PreTeL, Inc
Duke University; University of Rochester

Recruiting

Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients

Preterm Birth | Threatened Preterm Labor | PreTerm Labor

United States

Clinical Trials Sponsored by Duke University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations